Skip to content
Article Rich – Lifestyle
Author:
Conexeu Sciences Inc.
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
June 25, 2026
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
June 15, 2026
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
June 8, 2026
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
June 3, 2026
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
UPDATE – Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
UPDATE – Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026